Search - tctmd.com

Displaying 1 - 20 of 33

Sort: Relevancy | Date

Presentation TCT 2024

TCT 482: Anatomical Predictors for Blood Pressure Outcome After Endovascular Ultrasound Renal Denervation

Presenter: Karl Fengler

October 28, 2024

Presentation Cardiovascular Interventions 2023

MCS: Choosing the Right Device For the Right Patient

Presenter: Amir Kaki

November 10, 2023

Presentation TCT 2023

TCT 398: Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Six-Month Results Following Blinded Medication Titration in the Randomized, Sham-Controlled RADIANCE II Pivotal Trial

Presenter: Michel Azizi

October 25, 2023

Presentation TCT 2023

TCT 210: Long-term Safety and Efficacy of Endovascular Ultrasound Renal Denervation in Resistant Hypertension: 8-year results from the ACHIEVE study

Presenter: Victor Zeijen

October 25, 2023

Presentation TCT 2022

BPA for CTEPH: When and How?

Presenter: Vikas Aggarwal

September 19, 2022

Presentation TCT 2022

CTEPH? CTED? How Do We Make the Diagnosis?

Presenter: Riyaz Bashir

September 19, 2022

Presentation TCT 2022

Anticoagulation for PE: When to Switch to DOACs?

Presenter: Behnood Bikdeli

September 19, 2022

Presentation TCT 2022

Getting Smart With PE Diagnosis: The Role of AI

Presenter: Robert Lookstein

September 19, 2022

Presentation TCT 2022

CDT: New Devices, Drugs, and Duration?

Presenter: Andrew Sharp

September 19, 2022

Presentation TCT 2022

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomised Trial

Presenter: ShaoLiang Chen

September 18, 2022

Presentation TCT 2022

Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial

Presenter: Deepak Bhatt

September 18, 2022

Presentation TCT 2022

Case 2: COVID Patient With Clot in Transit

Presenter: Matthew Finn

September 18, 2022

Presentation TCT 2022

Novel Devices to Treat Hypertension: What Else Should We Expect in the Near Future?

Presenter: Felix Mahfoud

September 17, 2022

Presentation TCT 2022

Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation)

Presenter: Naomi Fisher

September 17, 2022

Presentation TCT 2022

Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation)

Presenter: David Kandzari

September 17, 2022

Presentation TCT 2022

Novel Approaches to Assess Hypertension Control Outside the Office

Presenter: Naomi Fisher

September 17, 2022

Presentation TCT 2022

Combination Therapy and Patient Outreach to Improve Adherence to Pharmacotherapies

Presenter: Melvin Lobo

September 17, 2022

Presentation TCT 2022

Dietary and Lifestyle Approaches to Hypertension Management: What’s New and What’s Changed

Presenter: Debbie Cohen

September 17, 2022

Presentation TCT 2022

Have We Gotten to the Final Word on Paclitaxel Safety?

Presenter: Eric Secemsky

September 17, 2022

Presentation TCT 2022

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

Presenter: Marc Bonaca

September 17, 2022

Advertisement

TCT 482: Anatomical Predictors for Blood Pressure Outcome After Endovascular Ultrasound Renal Denervation

MCS: Choosing the Right Device For the Right Patient

TCT 398: Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Six-Month Results Following Blinded Medication Titration in the Randomized, Sham-Controlled RADIANCE II Pivotal Trial

TCT 210: Long-term Safety and Efficacy of Endovascular Ultrasound Renal Denervation in Resistant Hypertension: 8-year results from the ACHIEVE study

BPA for CTEPH: When and How?

CTEPH? CTED? How Do We Make the Diagnosis?

Anticoagulation for PE: When to Switch to DOACs?

Getting Smart With PE Diagnosis: The Role of AI

CDT: New Devices, Drugs, and Duration?

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomised Trial

Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial

Case 2: COVID Patient With Clot in Transit

Novel Devices to Treat Hypertension: What Else Should We Expect in the Near Future?

Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation)

Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation)

Novel Approaches to Assess Hypertension Control Outside the Office

Combination Therapy and Patient Outreach to Improve Adherence to Pharmacotherapies

Dietary and Lifestyle Approaches to Hypertension Management: What’s New and What’s Changed

Have We Gotten to the Final Word on Paclitaxel Safety?

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content